Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$554M |
| 2 |
Apple
AAPL
|
+$513M |
| 3 |
Illumina
ILMN
|
+$360M |
| 4 |
argenx
ARGX
|
+$304M |
| 5 |
CTLT
CATALENT, INC.
CTLT
|
+$235M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$482M |
| 2 |
Sherwin-Williams
SHW
|
+$314M |
| 3 |
AbbVie
ABBV
|
+$310M |
| 4 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$244M |
| 5 |
Atlassian
TEAM
|
+$233M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.85% |
| 2 | Healthcare | 19.69% |
| 3 | Industrials | 10.47% |
| 4 | Financials | 10.02% |
| 5 | Consumer Discretionary | 9.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Healthpeak Properties
DOC
$14.4B
| $76.5M | 0.05% |
3,483,618
-389,097
| -10% | -$9.65M |
|
302
Berkshire Hathaway Class B
BRK.B
$1.14T
| $75.8M | 0.05% |
245,686
-199,886
| -45% | -$61.6M |
|
303
Bio-Techne
TECH
$11.2B
| $73.4M | 0.05% |
989,504
+3,162
| +0.3% | +$244K |
|
304
GE HealthCare
GEHC
$32.9B
| $72.4M | 0.05% |
+882,749
| New | +$63M |
|
305
Biohaven
BHVN
$2.19B
| $71.8M | 0.05% |
5,259,670
+697,159
| +15% | +$11.1M |
|
306
SITE Centers
SITC
$158M
| $71.8M | 0.05% |
7,494,611
+635,613
| +9% | +$6.45M |
|
307
Rexford Industrial Realty
REXR
$8.13B
| $71.6M | 0.05% |
1,201,206
-92,511
| -7% | -$5.54M |
|
308
Citigroup
C
$227B
| $71.2M | 0.05% |
1,519,521
+432,106
| +40% | +$21.2M |
|
309
PepsiCo
PEP
$188B
| $71.2M | 0.05% |
390,536
+54,928
| +16% | +$9.6M |
|
310
Zebra Technologies
ZBRA
$17.9B
| $71.2M | 0.05% |
223,754
+38,445
| +21% | +$11.6M |
|
|
FISV
311
Fiserv Inc
FISV
$27.8B
| $71M | 0.05% |
628,378
-2,961
| -0.5% | -$326K |
|
|
PDCE
312
DELISTED
PDC Energy, Inc.
PDCE
| $70.7M | 0.05% |
1,102,192
+302,025
| +38% | +$19.5M |
|
313
Equinix
EQIX
$103B
| $69.7M | 0.05% |
96,766
+6,213
| +7% | +$4.37M |
|
314
Wendy's
WEN
$1.39B
| $69.4M | 0.05% |
3,184,347
-419,720
| -12% | -$9.22M |
|
315
Black Hills Corp
BKH
$5.62B
| $68.8M | 0.05% |
1,090,839
+214,940
| +25% | +$14.2M |
|
|
CHX
316
DELISTED
ChampionX
CHX
| $68.5M | 0.05% |
2,523,816
-195,241
| -7% | -$5.83M |
|
317
Hartford Financial Services
HIG
$38.7B
| $67.3M | 0.04% |
966,007
+8,414
| +0.9% | +$625K |
|
318
HealthEquity
HQY
$8.93B
| $67.3M | 0.04% |
1,145,680
+55,922
| +5% | +$3.4M |
|
319
Leslie's
LESL
$10.4M
| $66.6M | 0.04% |
302,463
+27,349
| +10% | +$7.1M |
|
320
Chord Energy
CHRD
$7.8B
| $65.7M | 0.04% |
488,383
+73,778
| +18% | +$10M |
|
321
Helmerich & Payne
HP
$4.18B
| $65.6M | 0.04% |
1,835,983
+412,767
| +29% | +$17.8M |
|
322
Williams-Sonoma
WSM
$29.5B
| $65.4M | 0.04% |
1,075,502
+28,152
| +3% | +$1.76M |
|
|
CBAY
323
DELISTED
Cymabay Therapeutics
CBAY
| $65.4M | 0.04% |
7,496,049
+6,252,380
| +503% | +$50.1M |
|
324
Churchill Downs
CHDN
$6.02B
| $64.8M | 0.04% |
503,940
-29,748
| -6% | -$3.59M |
|
325
Ford
F
$55.8B
| $64.7M | 0.04% |
5,135,448
+4,648,981
| +956% | +$58.2M |
|
Similar funds
Janus Henderson Group's Q1 2023 Portfolio in Review
As of Q1 2023, Janus Henderson Group held 2,845 positions worth $152B, up 8.3% from $140B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Janus Henderson Group's Q1 2023 filing shows 389 new, 1,670 increased, 578 reduced and 160 closed positions. Its largest new stake was GE HealthCare: 882,749 shares worth $72.4M. The largest sale was Meta Platforms (Facebook), an estimated $482M.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 28% a quarter earlier, followed by Healthcare and Industrials.
- Janus Henderson Group's largest Q1 2023 buy was GE HealthCare: 882,749 shares worth $72.4M.
- Janus Henderson Group added most to Linde in Q1 2023, an estimated $554M increase.
- Janus Henderson Group's biggest Q1 2023 reduction was Meta Platforms (Facebook), cutting an estimated $482M.
- Janus Henderson Group fully exited Myovant Sciences Ltd. in Q1 2023, selling an estimated $31.7M.
- Janus Henderson Group's ten largest holdings make up 24% of its $152B portfolio in Q1 2023.
- Janus Henderson Group opened 389 new positions and closed 160 in Q1 2023.
- Janus Henderson Group's portfolio value rose 8.3% quarter-over-quarter to $152B.
Based on Janus Henderson Group's 13F filing for Q1 2023, filed 15 May 2023.